US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

INVA

Innoviva (INVA)

Innoviva Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INVA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	05 : 46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INVA	Innoviva Inc
2024/05/09	05 : 44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVA	Innoviva Inc
2024/05/09	05 : 05	Business Wire	Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress	NASDAQ:INVA	Innoviva Inc
2024/05/08	20 : 00	Business Wire	Innoviva to Participate in the BofA Securities Health Care Conference	NASDAQ:INVA	Innoviva Inc
2024/04/24	20 : 00	Business Wire	Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024	NASDAQ:INVA	Innoviva Inc
2024/03/08	09 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/03/08	09 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/03/08	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/03/08	08 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/03/01	07 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:INVA	Innoviva Inc
2024/03/01	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVA	Innoviva Inc
2024/03/01	06 : 05	Business Wire	Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress	NASDAQ:INVA	Innoviva Inc
2024/02/23	11 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/02/23	11 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/02/14	21 : 23	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INVA	Innoviva Inc
2024/01/23	11 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2024/01/23	04 : 03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INVA	Innoviva Inc
2024/01/11	10 : 26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/11/18	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/11/06	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVA	Innoviva Inc
2023/11/02	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVA	Innoviva Inc
2023/11/02	05 : 15	Business Wire	Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:INVA	Innoviva Inc
2023/11/02	05 : 05	Business Wire	Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea	NASDAQ:INVA	Innoviva Inc
2023/09/19	21 : 30	Business Wire	Innoviva to Participate in the Cantor Global Healthcare Conference	NASDAQ:INVA	Innoviva Inc
2023/09/18	21 : 00	Business Wire	XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults	NASDAQ:INVA	Innoviva Inc
2023/09/01	09 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/09/01	09 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/09/01	09 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/09/01	09 : 10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc
2023/09/01	09 : 10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:INVA	Innoviva Inc

Showing the most relevant articles for your search:NASDAQ:INVA

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

Financial Select Sector

JP Morgan Chase

US Dollar vs Sterling

US Dollar vs Euro

Health Care Select Sector

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約